The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds. By Nicole Sperling Illumina, the leading producer of gene-sequencing machines, ...
Illumina (NASDAQ:ILMN) supports global genomic science as nasdaq futures discussions include advanced life sciences platforms ...
San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...
Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...
Illumina, Inc.'s acquisition of GRAIL, Inc. was disastrous and created all kinds of problems, but the company is refocusing on its profitable core gene sequencing business. ILMN's revenue growth has ...
Why Illumina’s Latest Move Has Investors Watching Closely Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive ...
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s part ...
A new Global Health Access Initiative, launched by Illumina, is designed to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program will ...
SAN FRANCISCO—Illumina’s new CEO Jacob Thaysen, PhD, shared the sequencing giant’s 2024 priorities and presented preliminary fourth-quarter and full-year 2023 results that beat Wall Street forecasts ...
Illumina’s announced partnerships with IBM’s Watson and Philips help shore up the firm's data-analysis capabilities and clinical diagnostic marketing efforts, respectively, but the announcement of a ...
Learn more about whether Charles River Laboratories International, Inc. or Illumina, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...